173 related articles for article (PubMed ID: 2954459)
1. A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.
Zokaeem G; Bayleran J; Kaplan P; Hechtman P; Neufeld EF
Am J Hum Genet; 1987 Jun; 40(6):537-47. PubMed ID: 2954459
[TBL] [Abstract][Full Text] [Related]
2. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
3. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
Paw BH; Neufeld EF
J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
[TBL] [Abstract][Full Text] [Related]
4. Tay-Sachs disease: B1 variant.
Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
[TBL] [Abstract][Full Text] [Related]
5. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
[TBL] [Abstract][Full Text] [Related]
6. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.
Ozkara HA; Sandhoff K
Brain Dev; 2003 Apr; 25(3):191-4. PubMed ID: 12689698
[TBL] [Abstract][Full Text] [Related]
8. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells.
Guidotti J; Akli S; Castelnau-Ptakhine L; Kahn A; Poenaru L
Hum Mol Genet; 1998 May; 7(5):831-8. PubMed ID: 9536087
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.
Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A
Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859
[TBL] [Abstract][Full Text] [Related]
11. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
[No Abstract] [Full Text] [Related]
12. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
[TBL] [Abstract][Full Text] [Related]
13. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
Brown CA; Mahuran DJ
J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.
Proia RL; Neufeld EF
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6360-4. PubMed ID: 6959123
[TBL] [Abstract][Full Text] [Related]
15. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
[TBL] [Abstract][Full Text] [Related]
16. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
[TBL] [Abstract][Full Text] [Related]
17. Hexosaminidase A deficient adults: presence of alpha chain precursor in cultured skin fibroblasts.
Frisch A; Baram D; Navon R
Biochem Biophys Res Commun; 1984 Feb; 119(1):101-7. PubMed ID: 6231027
[TBL] [Abstract][Full Text] [Related]
18. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
Hechtman P; Khoo K; Isaacs C
Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
[TBL] [Abstract][Full Text] [Related]
19. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
20. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
